Pr Jean-Yves Blay
- Spécialité
- Oncologue médical, expert sarcomes
- Titre
- Directeur Général
- Hôpital
- Centre Léon Bérard (Lyon)
- Derniers articles
-
- Long-term efficacy and safety of pexidartinib in patients with tenosynovial giant cell tumor: final results of the ENLIVEN study. (4 juil. 2025)
- Postoperative radiotherapy in patients with R0 resection of soft tissue sarcoma: results from the European sarcoma CONTICABASE analysis. (3 juil. 2025)
- Phase I First-in-Human Study of TRK-950, an IgG1 Antibody Specific to CAPRIN-1, in Patients with Advanced Solid Tumors. (1 juil. 2025)
- The economic and humanistic burden of tenosynovial giant cell tumor: a targeted literature review. (22 juin 2025)
- Radiopharmaceutical application of TRK-950, an anti-CAPRIN-1 therapeutic antibody. (5 juin 2025)